hirschsprung's disease: etiology and pathophysiology · 2018. 10. 12. · hirschsprung's disease:...
TRANSCRIPT
-
4 1 ;t.°l £.jJ!j- : ;\1] 8 Ti ;
-
42
NORMAL HIRSCHSPRUNG'S DISEASE
Fig. 1. Schematic presentation of the enteric nervous system of the normal (left) and aganglionic (right) bowel wall (E; excitatory fibers, I; inhibitory fibers , NO; nitric oxide)1.
~O):oJ] s:.'?dS'lT?1A1 ]:l]£~ 1J%3i ~ ~ ~~o] £~] S'l 7 ] A] ~
"6}~ql.
~}.t&3i.2..£-c neural crest cell (NCC)oJ] A1 7]~~ GC-&
'T- Ell .f 5i'- 73 oj] ~ s:. oj] s:. ~~ .f "tJ-it ~.2..£ AJ-~ % uj-2.} 0] %"6} u:j , 'T- Ell .f 12i'- 73 oJ] -c "6}-¥- ~ AJ-oJ] s:. ~~ L} ~
AJ--¥! ~.2..£ o]%~ GC-c ~ AJ--¥! ~.J..J-t- (circular muscle) 9.] -¥-oJ] AJ3}"6}o-~ AJ-t---873 % (myenteric plexus)% f:§}.j "6}u:j , %i'-t- (longitudinal muscle) 0] :J.. ~{% -tl .f GC-& fibr-onectinit} hyaluronic acid % glycoprotein.91 % s:. ~ ~.2.. T?1
A1 ~.J..Jt-% l.J1 ~.2..£ -¥!% "6}O:j 11 ~"6}~oJ] 0] ~ .f 11 ~"6}
--873% (submucous plexus)% f:§ .J..j~q. ·~Pj -¥-~~] NCC
.91 0]% it}Aj.91 ~rrJl -c GC.91 -¥- lR~ 0):7 ] A] ~ 'T- c;).2..E.£2,
NCC~ 0]% it}Ac]oJ] -¥!O:j"6}~ O:j l~ ~ A}%.91 ¥-~ ol HD.91
~~~ 1!.2..£ ~Jl c;)q. :E~ 0] it}AjoJ] -¥!O:j"6}-c O:j l~ ~
A}%.91 -¥-~-& *~~3i~ ~~%oJ] .91"6}O:j ~7cl 7.]~~ 1! 0] c}-c l1oJV1 %~~3i~ ~~~o] A}C11f71] ~ 1!o]q.
~AJ--¥! -g-%-& 9.] ~}.j --873ll]oJH -¥-.llL~--8 73 1l].91 --8 73 ~
~ ~* (preganglionic fiber) 7} 'T-~% i'-s:. "6}Jl, .llL~--8 73 1l]
.91 --873~ .f ~% (postganglionic fiber)7) Q:j l~]~%% "6}u:j ,
0:j7]oJ] l.J1~.J..j --8731l]~ ]:l].llL~- ]:l]-¥-.llL~ --8731l] (non-
adrenergic, non-cholinergic, NANC).91 ~ ~ uR ;'\1] ~ nitrous
oxide (NO).91 }'~Aa% %"6}O:j :iIH;[t- 'T-~ Q:j l~]~%% "6}T?1
-"1 itf:§1f~ '?:I%% i'-s:."6} 71] ~q3. ~Ell }.~C1~3i.2..£-c 0]
l1~ AJl.J1 {}73%.91 -¥-lR7} NANC {} 73 Q:j l~] UH;'\1]~ NO }.~ }.j AJ-°H~ ~.2..7:1 AJ--¥! Ll1 ~~t-.91 o]-'tl- AJ- oH7} ~A~"6}-C ?;!4.2...£ ~t;jA=j c;)q (:J..'fJ 1). NO~ A~ Aj -& 3:6] l.J1 NO
synthase(NOS) 01] .91 "6}-c 1!.2..£ HD ~ A} ~ {} 731l. A1] ~ -¥-
lR -¥- ~oJ] -"l NOS7} %}.j.2...£ y-qy-u:j, tH~-¥-~ t-~3:6] 2.] RT-PCR01] A1 NOS mRNA~ ~~o] ~~~ 11°] o] ~
%! ]:l}~"6} Jl ~) c.].5.6 ~. 'B. ~1J'-¥! }IJ~t- -g-%~ pace-maker£ ~%"6}~ n~
A~] ~~ 7'}W Al]~ (interstitial cell of Cajal)-c r1VJ- If---873~
%% ~.2..7' ] -c u}-9-:::'::: .2. \:~ (lethal spotted mice).91 ~~ -¥-
~~ If---873 ~ AJ-{!-~q AJ-¥- AJ-{!-01]-"l NOS.91 ~~% ~~
~} {}73 ~A~] ~ 'T- ~ neuropeptides.91 ~~7} ~7l1] L.J-qy--c
11 7% ~o} HD.91 ~ER A~C19} ~o] '?:I-¥!S'l~c;).2..u:j, ~"6] HD
'T-1f .f ~*"6}-c AJ- -g-% AJ-°R%.91 ~~.2..'£ ~Jl ~q. -1 3:-3:j.2..£ }IJ ~t- l.H~ 7'}W "'1]~-c --873%it} ~~~.2..£ ~~
"6}1?1-"l -"1£7} '?:I ~ S'l~ c;).2..u:j, --81"'1]~9} :iIJ~t-0] %--']
01] OJ T?1.2..£ 1j ~S'l~ c;).2..u:j8,9, NO signaling oj] rJI~ '?:I-1 ~ it} {}1Al]~£-¥-E1 }.~ }.j~ NO-c 7'}W A1]~~ ~~}~ lE-3:j
%£ "6}Jl c;) .2..u:j, :J.. q% :iIJ~t-.2..£ {}~7} ~1tS'l~ 0]
-'tl-~%% "6}-c 1!.2..£ ~0}1O HD.91 o]-'tl-AJoR 7]~oJ] 7'}W
Al]~7} ~ o] {!-1l]S'l~ c;)%o] ~~"6}qJl ~q. :J..ciL.J- * AJ-'?:l %}.j ~~01H 7'}W Al]~ 'T-7} ~~~ 1:]1l it} q~ '?:l%
Aj AJ- ~~01] A1 S=_ ~ AJ-{!- -g-%AJ-oH9} ~7l1] 7'}W A~l~ 'T-7} ~~"6}-c 1112 %.2..£ ~o} AJ--g-%AJ-0R.91 ~~~A] ~it}~7.]
-c 0}-0.js:. .2.~~ 7}-g-[1] 'i!.2..£.91 '?:I-1~ %"6}O:j ~q ~~
"6] ~{-&1 A~O): W -¥-~ o]q. %~~3i.2..~ HD-c %~ 7}1l] l.H01H ~Aj~ Aas:.~ 0]
~%% ~o]Jl ~)q. ~"6] 7}~t:"jO] c;)-c HDY- %~~}.a
HD ~A}01]-"l RET %~A} ~0]7} ~~~ ~l{!- 0tyc}13,14
glial cell line-derived neurotrophic factor (GDNF) genel5,
endothelin-B receptor (EDN-BR) gene ~ endothelin-3
(EDN-3) gene % 3 7}A].91 ~~ *~A7} ~z!:rjJl c;)Jl, 4.5-16 %01jJ'l c.].-g- %.fTo] %l{}s:j-c % '?:l~;'\1] O]AJ-s:. ~
Z!~q-c 1:]01H %;;i~ R~7} ~ ~A~01] ~o] (?H!-:rj~ c;)
-c 1!.2..£ ~Jl~JqI6. ~"6] 1J~%%01H RET Al]ll u}-9-:::':::
01]-"1 ;;i rJl AJ-f:§ If-{} 1 ~ %0] y-qy-Jl, :J.. If-{l11i AJ--¥!01]
-"1 RET mRNA ~~o] ~~~ 1117-& *;;i~~ ~~~.91 1J
%~~ %71£ ~ 'T- ~)q.
Martucciello (1992)18%-& ~ i~-& O:jA}.91 ;;irJIAJ-f:§ HD01]
A1 '?:l ~ ;'\1] lOJti.91 interstital deletion (ql1.21-q21.2)0] "'R £
0] ~A~~ 1!% ~Jl"6}Jl, '?:l~;'\1] lOJti.91 proximal long arm
01] c;) -c HD *~jA A]s:.~ ~}.j"6}~q. Lyonnet %19-& %.f
Tit) -¥!1l]\lt-c 15oj]~ ~ ~1l.f:§ ~ fJ--& ~1l.f:§ lID 7}~.91
%;;i7.}~ 3:A}"6}O~ HD~ -9-}.j %;;i7.}7} q-e nural crest
defcet9}s:. -¥!1l]~ -¥-~£ ~t;jA~ c;)-c lOqll.2~% ~ll] s:j
-
°1~ I2:j : Hirsc h s Pl'ung's Di sease: Et iology a nd Pathop hys iolo gy 43
~.2..o1, r}-e Of- '?1 -=]L .::1*20.21-& 0] HD %~A}~ nET
proto-concogeneOl] J.l5:. ~;;:! ol71] ~l 7~ 0] c1'. 0] ('1 ~ '?1lL ~ J!] *-% i'--Wo}o~ .ltlC! missense *-& nonsense mutationJ!]
~ 7H 9.] ~ 7] t1H ~ ~i21' *-& nET proto-concogene2] !.J'ici ~AJo] 7]·~i2=j~ ~),~o]Ll ~~.~ i=- iJj]Qj ~~olo1 ?:>·~:l , ~o]
{l ~~i5J *-& ~ AJ:jl}i5J HD-c RET7} ~~ %~A}O]o1. GDNF-RETQj signaling cascade7} 'l:l ~A~ 7]~0]('l.Jl .It
.Jl ~ cf~.
i'- -Wo} o-~ 7 ]'~ -'§-% J'l'2.j=o}lC! 'l:l~~-& 3.111 Of- 7} A]£ cJ1
~~. 4'- ~c}. ~ (1) GC9-] 01%1J7:1] 9-] ~jjHQ} (2) ti:!~~~
~ li~ %o]r-t. ti:!~ ~~~ li~-& ~l-% ~101Vl J.,iuJ~ oj]
AaO]r-t.
o]AJQj Z{ li~-'§--& Z{Z{.2..£ *-& ~ 7}A]7} %~£] ti:!J-l
~·VJ~~ ~'l:l J.J E117} LlE}Ll71] £] -c c~] o] -'§- zJ li~*- Qj 4 % 1Jl!]~ .ltc1. A~] ~i5}~ {!~ ~A}-'§-Qj ~W:% li'2.j=~qti:!
o}lHQ} ~o] Aa ~W: 4'- ~c}.
n GC 0] % ~lI\1 (migration fai lure); ~~-& 0}3J ~ .2-.s. Ll A1] ¥'.21 7] ~ (extracellular matrix, ECIVOJ!} A1] ¥. %;3}%~ (cell adhesion molecules, CAM) 0] {!-7:1]7} 9)
2). GC 0]% .f Aa;3} ~lI\1 (failure to survive); iiJ{l~~
A} (neurotrophic factor, NF)9-] {}~
3). GC -If-:.& ~lI\1 (fai lure of differentiation) ; ECM BBJl ~ 9-] ~:.&, ICAM-l Qj ~ ~
4). *~~ li~ ; °d~~l] o]AJ, %~A} ~01, RET, GDNF,
END-BR ~ Et\JD-3 %~A]'
5). ti:!~~~ .&~ ; MHC class-IT Ag ~~
%.2..£ L-}~ 4'- ~ q,
'l:l ~),~on {!-~i5}-c Z{ li~ -'§- Qj 'l:l ~),EOl] {!~o}-c 71
~-& 0}C1lQ} ~c}.
~~~ ~1¥.9} ECM : NCCQj 01%, Aa~' ~ J.a4;'- J!}Aa
Ol] -c ~('1 i'-%Qj ECMol {!~~q.Jl ~cl·. AJ jjd~-c A1]¥.
-c NCC.21 01% J-10l] lE~ *£~A} (targeting or guiding)
£ 4%~r-t.Jl i5}-ccll, HD ~Al£-¥-fl '
-
44
curse %.f-;r %0] % Jfr.
-
°l ~ 12:1 : Hirsc h s prung's Disease : Etiology a nd Pathophys iology 45
10. Salmhofer H, Neuhuber WL, Ruth P, Huber A,
Russwurm M, Al lescher HD: Pivotal role of the
interstitial cells of Cajal in the nitric oxide signaling
pathway at small intestine. Morphological evidence. Cell
Tiss Res 305:331-340, 2001
II. Faussone-Pellegrini MS, Gay J, Vannucchi MG, Corsani
L, Fioramonti J: Alterations of neurokinin receptors and
interstitial cells of Cajal during and after jejunal
inflammation induced by Nippostrongylus brasiliensis in
the rat. Neurogstro Mot 14:83-95, 2002
12. Sanders KM, Ordog T, Ward SM: Physiology and
pathophysiology of the interstitial cells of Cajal. .fi·om
bench to bedside. IV Genetic and animal models of GI
motility disorders caused by loss of interstitial cells of
Caja/. Am J Physiol Gastroint Liv Physiol 282:G747-756,
2002
13. Geneste 0, Bidaud D, De Vita G, Hofstra RM,
Tartare-Deckert S, Buys CH, Lenoir GM, Santoro M,
Billaud M: Two distinct mutations of the RET receptor
causing Hirschsprung's disease impair the binding of
signaling effectors to a multifunctional docking site.
Human Mol Genet 8: 1989-1999, 1999
14. Inoue K, Shimotake T, Inoue K, Tokiwa K, Iwai N:
Mutational analysis of the RET proto-oncogene in a
kindred with multiple endocrine neoplasia type 2A and
Hirschsprung's disease. J Pediatr Surg 34: 1552-1554,
1999
15. Cariomagno F, Mellilo RM, Visconti R, Salvatore G,
De Vita G, Lupoli G, Yu Y, Jing S, Vecchio G, Fusco
A, Santoro M: Glial cell line-derived neurotrophic
factor differentially stimulates ret mutants associated
with multiple endocrine neoplasia type 2 syndromes and
Hirschsprung's disease. Endocrinology 139:3613-3619,
1998
16. Puri P: Preface: Hirschsprung's disease and related
disorders-recent progress. Semin Pediatr Surg 7: 137-139,
1998
17. Zhan J, Xiu Y, Gu J, Fang Z, Hu XL: Expression of RET
proto-oncogene and GDNF deficit in Hirschsprung's
disease. J Pediatr Surg 34: 1606-1609, 1999
18. Martucciello G, Favre A, Kakahashi M, V Jasonni:
Immunohistochemical localization of RET protein in
Hirschsprung's disease. J Pediatr Surg 30:433-436, 1995
19. Lyonnet S. Bolino A. Pelet A. Abel L. Nihoul-Fekete C.
Briard ML. Mok-Siu V. Kaariainen H. Martucciello G.
Lerone M: A gene for Hirschsprung disease maps to the
proximal long arm of chromosome 10. Nature Genetics
4:346-350, 1993
20. Romeo G. Ronchetto P. Luo Y. Barone V. Seri M.
Ceccherini I. Pasini B. Bocciardi R. Lerone M. Kaariainen
H: Point mutations affecting the tyrosine kinase domain of
the RET proto-oncogene in Hirschsprung's disease. Nature.
367:377-378, 1994
2 1. Edery P. Lyonnet S. Mulligan LM. Pelet A. Dow E.
Abel L. Holder S. Nihoul-Fekete C. Ponder BA.
Munnich A: Mutations of the RET proto-oncogene in
Hirschsprung's disease. Nature. 367:378-380, 1994
22. Angrist M. Bolk S. Thiel B. Puffenberger EG. Hofstra
RM. Buys CH. Cass DT. Chakravarti A: Mutation
analysis of the RET receptor tyrosine kinase in
Hirschsprung disease. Hum Mol Genet 4:821-30, 1995
23: Attie T. Pelet A. Edery P. Eng C. Mulligan LM. Amiel
J. Boutrand L. Beldjord C. Nihoul-Fekete C. Munnich
A: Diversity of RET proto-oncogene mutations in fami-
lial and sporadic Hirschsprung disease. Hum Mol Genet
4:1381-1386, 1995.
24. Martucciello G, Thompson H, Mazzola C,A Morando,
M Bertagnon, F Negri, A Brizzolara, L Rocchetti, C
Gambini, V Jasonni: GDNF deficit in Hirschsprung's
disease. J Pediatr Surg 33 :99-102, 1998
25. Langer JC, Betti PA, Blennerhassett MG: Smooth
muscle from aganglionic bowel in Hirschsprung's
disease impairs neuronal development in vitro. Cell Ti-
ssue Res 276:181-186, 1994
26. Kamagata S, Donahoe PK: The feect of fibronectin on
cholinergic differentiation of the fetal colon. J Pediatr
Surg 20:307-314, 1985
27. Pormeranz HD, Rothman TP, Chalazonitis A, Tennyson
VM. Gershon MD: Neural crest-derived cells isolated
from the gut by immunoselection develop neural and
glial phenotypes when cultured on laminin. Develop
BioI 156:341-361, 1993
28. Gershon MD, Chalazonitis A, Rothman TP: From neural
crest to bowel: Development of the enteral nervous
system. J Neurobiol 24:199-214, 1993
29. Fujimoto T, Hata J, Yokoyama S, Mitomi T: A study of
the extracellular matrix protein as the migration pathway
of neural crest cells in the gut: Analysis in human
emblYos with special reference to the pathogenesis of
Hirschsprung's disease. J Pediatr Surg 24:550-556, 1989
30. Chalazonitis A, Rothman TP, Chen Jx, Lamballe F.
Barbacid M. Gershon MD: Neurotrophin-3 induces neural
crest-derived cells from fetal rat gut to develop in vitro as
neurons or glia. J Neurosci 14:6571 -6584, 1994
31. Ohshiro K, Puri P: Reduced glial cell line-derived
neurotrophic factor level in aganglioniC bowel in
Hirschsprung's disease. J Pediatr Surg 33:904-908, 1998
32. Covault J, Sanea JR: distribution of N-CAM in synaptic
and extrasynapticportions of developing and adult skeletal
muscle. J Cell Bioi 102:716-730, 1986
-
46
33. Gordon L, Whalton J, Moore SE, Walsh FS. Moscoso
JG. Penketh R. Wallwork 1. Taylor KM. Yacoub MH.
Polak JM: Myocardial localization and isoforms of
neural cell adhesion molecules(N-CAM) in the devel-
oping and transplanted human heart. J Clin Invest
86: 1293- 1330, 1990, cited from Puri seminar
34. Romanska HM, Bishop AE, Brereton RJ, Spitz L. Polak
JM: Increased expression of muscular neural cell adhesion
molecule in congenital aganglionosis. Gastroenterology
105:1104-1109, 1993
35. Kobayashi H, O'Briain DS, Puri P: Lack of expression
of NADPH-diaphorase and neural cell adhesion mo-
lecule(NCAM) in colonic muscle of patients with Hir-
schsprung's disease. J Pediatr surg 29:301-304, 1994
36. Ikawa H, Kawano H, Takeda Y, Masuyama H. Watanabe
K. Endo M. Yokoyama J. Kitajima M. Uyemura K.
Kawamura K: Impaired expression of neural cell adhesion
molecule Ll in the extrinsic nerve fibers in Hirschsprung's
disease. J Pediatr Surg 32:542-545, 1997
37. Kamiguchi H, Lemmon V: Neural cell adhesion
moilecule LI: Signaling pathways and growth cone
motility. J Neurosci Res 49: 1-8, 1997
38. Okamoto N, Wada Y, Goto M: Hydrocephalus and
Hirschsprung's disease in a patient with a mutation of
LICAM J Med Genet 34:670-671 , 1997
39. Puri P, Ohshiro K, Wester T: Hirschsprung's disease: A
search for etiology. Semin Pediatr Surg 7:140-1 47, 1998
40. Bardner lA, Chakravarti A: Waardenburg syndrome and
Hirschsprung's disease: Evidence for pleotropic effects of
a single dominant gene. Am J Med Genet 35:100-104,
1990
41. Kusafuka T, Puri P: Genetic aspects of Hirschsprungs
disease. Semin Pediatr Surg 7: 148-155, 1998
42. Pingault V, Bondurand N, Kuhlbrodt K, Georich DE, Prehu
MO, Puliti A, Herbarth B, Hermans-Borgmeyer I, Legius E,
Matthjs G, Amiel J, Lyonnet S, Cecchrini I, Romeo G,
Smith JC, Read AP, Wegner M, Goossens M: SOX10
mutations in patients with Waadenburg-Hirschsprung disease.
Nat Genet 18:171-1 73, 1998
43. Moore SW, Johnson AG: Hirschsprung's disease: genetic
and fUnctional associations of Down's and Waardenburg
syndromes. Semin Pediatr Surg 7:156-161, 1998
44. Sakai T, Wakizaka A, Matsuda H, Nirasawa Y, Hoh Y:
Point mutation in exon 12 of the receptor tyrosine
kinase proto-oncogene RET in Ondine-Hirschsprung
syndrome. Pediatrics 101 :924-926, 1998
45. Urushihara N, Nakagawa Y, Tanaka N, Uemura N,
Yoshida A: Ordine's curse and Hirschsprung's disease;
neurocristopathic syndrome. J Pediatr Surg 9:430-432,
1999
46. Luo Y. Ceccherini l. Pasini B. Matera I. Bicocchi MP.
Barone V. Bocciardi R. Kaariainen H. Weber D. Devoto
M : Close linkage with the RET protooncogene and
boundaries of deletion mutations in autosomal dominant
Hirschsprung's disease. Hum Mol Genet 2: 1803-1808,
1993
47. Oosma M.P, Cardone M, Cariomagno F, Coiantuoni V:
Mutations in the extracellular domain cause RET loss of
function by a dominant negative mechanism. Molec Cell
Bioi 18:3321-3329, 1998
48. Pelet A, Geneste 0, Edery P, Pasini A, Chappuis S, Atti
T, Munnich A, Lenoir G, Lyonnet S, Billaud M: Various
mechanisms cause RET-mediated signaling defects in
Hirschsprung's disease. J Clin Invest 101:1415-1423, 1998
49. Sancandi M, Ceccherini I, Costa M, Fava M, Chen B,
Wu Y, Hofstra R, Laurie T, Griffihs M, Burge D, Tam
PK: Incidence of RET mutations in patients with
Hirschsprung's disease. J Pediatr surg 35 :139-142, 2000
50. Martucciello G, Thompson H, Mazzola C, Morando A,
Bertagnon M, Negri F, Brizzolara A, Rocchetti L,
Gambini C, Jasonni V: GDNF deficit in Hirschsprung's
disease. J Pediatr Surg 33 :99-102, 1998
51. Hosoda K. Hammer RE. Richardson JA. Baynash AG.
Cheung Je. Giaid A. Yanagisawa M: Targeted and natural (piebald-lethal) mutations of endothelin-B
receptor gene produce megacolon associated with
spotted coat color in mice. Cell 79: 1267-76, 1994
52. Tanaka H, Moroi K, Iwai J, Takahashi H, Ohnuma N,
Hori S, Takimoto M, Nishiyama M, Masaki T,
Yanagisawa M, Sekiya S, Kimura S: Novel mutations of
the endothelin B receptor gene in patients with
Hirschsprung's disease and their characterization. 1 Bioi
Chern 273:11378-11383,1998
53 . Oue T, Puri P: Altered endothelin-3 and endothelin-B
receptor mRNA expression in Hirschsprung's disease. J
Pediatr Surg 34:1257-1260, 1999
54. Woodward MN, Kenny SE, Vaillant C, Lloyd DA, Edgar
DH: Time-dependent effects of endothelin-3 on enteric
nervous system development in an organ culture model of
Hirschsprung's disease. J Pediatr Surg 35:25-29, 2000
55. Yanagisawa M: Endothelins in development of neural
crest derived tissue. Presented at the 2nd Intematinal
Meeting: Hirschsprung's and related neurocristopathies.
Cleveland, OH, October 1995, cited from KusafUka T,
Puri P: Genetic aspects of Hirschsprungs disease.
Semin Pediatr Surg 7:148-155, 1998
56. Pingault V. Puliti A. Prehu MO. Samadi A. Bondurand
N. Goossens M: Human homology and candidate genes
for the Dominant megacolon locus, a mouse model of
Hirschsprung's disease. Genomics. 39:86-9, 1997
-
01 qJ 12] : Hirsc hsp run g's D isease Etio logy and P aLhop h ysiology 47
57. Kuroda T, Doody DP, Donahoe PK: Aberrant colonic
expression of MHC class If antigens in Hirschsprung's
disease. Aust NZ J Surg 61 :373-179, 199 1
58. Hirobe S. Doody DP. Ryan DP. Kim SH. Donahoe PK:
Ectopic class If major histocompatibility antigens in
Hirschsprung's disease and neuronal intestinal dysplasia.
J Pedialr Surg 27:357-62; 1992
59. Kobayashi H, Hirakawa H, Puri P: Overexpression of
intercellular adhesion molecule-l(ICAM-I) and MIle class
II antigen on hypertrophic nerve trunks suggests an
immunopathologic response in Hirschsprung's disease. J
Pediatr Surg 30: 1680-1683, 1995